Thriving Awareness about Cervical Cancer Programs, thanks to Government Initiatives to Boost Cervical Dysplasia Market

With an aim of preventing several types of cancers, governments across the globe are increasingly funding for healthcare screening programs. This is auguring well for the global cervical dysplasia market. Owing to such initiatives by government, a number of people are coming forward to undergo cervical screening tests such as HPV, colposcopy, and Pap smear. Thus, this is an important driver for the market. According to a report published by Transparency Market Research, the global cervical dysplasia market is expected to rise from US$349.0 mn in 2015 to US$ 640.2 mn by 2024, expanding at a 7% CAGR from 2016 to 2024. 

Get Research Report:

In this blog post, TMR answers three critical questions about the cervical dysplasia market:

Q. Of the three diagnosis tests, which test is expected to witness a higher adoption?

The global cervical dysplasia market can be segmented on the basis of diagnosis tests into Pap smear, HPV, and biopsy test. Of these, it is most likely that the HPV test segment will witness a surge in terms of adoption rates. This is because, Pap smear tests have a higher false-negative rate as well as costly. In contrast to this, HPV tests are accurate, cost-effective, and have seen several advancements in terms of technology, thus driving their adoption or demand. A number of healthcare providers are thus, preferring and recommending HPV testing as a primary screening tool. 

Q. What are the opportunities for growth in the global cervical dysplasia market?

 Emerging economies hold stupendous growth opportunities for the cervical dysplasia market. Currently the penetration of cervical dysplasia devices in emerging economies is low and this is expected to make these untapped markets lucrative in the near future. Players in the market can thus, invest in aggressive promotional campaigns in emerging nations as these nations have very high number of cervical cancer deaths. It has been found that 90% of the deaths due to cervical cancer are occurring in these countries on a yearly basis. 

Q. Which region is leading in the cervical dysplasia market?

North America is leading in the global cervical dysplasia market. The region accounted for 55.2% of the market in 2015. The growth of the market in this region is estimated due to increasing awareness among people regarding the cervical dysplasia screening programs. Screening devices have become technologically advanced and this is also driving the demand for these devices in North America. Moreover, cervical cancer among women above the age of 50 was 85% in 2015 and this is also creating a conducive environment for the growth of the cervical dysplasia market in this region. In addition to this, federal organizations have favorable reimbursement policies, which is furthering the growth of the market. Over the years, Asia Pacific and Latin America are also expected to witness a growth. 


Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports